Copyright
©The Author(s) 2022.
World J Clin Cases. Nov 16, 2022; 10(32): 11775-11788
Published online Nov 16, 2022. doi: 10.12998/wjcc.v10.i32.11775
Published online Nov 16, 2022. doi: 10.12998/wjcc.v10.i32.11775
Figure 1 Flowchart of patient enrollment.
CRS: cytoreductive surgery; HIPEC: hyperthermic intraperitoneal chemotherapy.
- Citation: Wang YF, Wang TY, Liao TT, Lin MH, Huang TH, Hsieh MC, Chen VCH, Lee LW, Huang WS, Chen CY. Quality of life and symptom distress after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Clin Cases 2022; 10(32): 11775-11788
- URL: https://www.wjgnet.com/2307-8960/full/v10/i32/11775.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i32.11775